Sinopharm Group 

$11.01
59
+$0.19+1.72% 今天

統計

當日最高
11.01
當日最低
11.01
52週高點
14.87
52週低點
10.57
成交量
1,153
平均成交量
86,404
市值
34.36B
本益比
6.38
股息殖利率
4.71%
股息
0.52

即將到來

股息

4.71%股息殖利率
Aug 25
$0.47
Aug 24
$0.61
Aug 23
$0.57
Sep 22
$0.56
Aug 21
$0.54
10年成長
5.06%
5年成長
-1.12%
3年成長
-3.91%
1年成長
8.46%

財報

31Aug預期
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
下一步
1.06
1.29
1.52
1.75
預期EPS
1.26240980715
實際EPS
不適用

財務

1.21%利潤率
有盈利
2019
2020
2021
2022
2023
2024
160.38B營收
1.93B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 SHTDY 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Sinopharm Group Co. Ltd. is a prominent Chinese enterprise specializing in the wholesale and retail of pharmaceuticals, medical devices, and other healthcare products. The company's diverse operations are structured into four key segments. The Pharmaceutical Distribution segment is responsible for supplying a wide array of pharmaceutical products to various healthcare entities, including hospitals, clinics, and retail pharmacies. This segment also provides comprehensive logistics and value-added services to both domestic and international manufacturers and suppliers of pharmaceutical and healthcare items. The Medical Devices segment focuses specifically on the distribution of medical equipment. Through its Retail Pharmacy segment, the company operates and franchises an extensive chain of drugstores, which totaled 10,259 locations as of December 31, 2021. The Other Business segment encompasses the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core activities, Sinopharm Group also engages in property rental and management, distributes specialized products such as Chinese herbal medicines, antibiotics, and biological products, and offers a suite of services. These include IT development, medicine, business, health, and market information consulting, international trade (import/export of goods and technology), market investigation, and convention and exhibition services. Furthermore, the company is involved in medical project investment, consulting, and technology training. To enhance its commercial capabilities and transformation, Sinopharm Group Co. Ltd. maintains a strategic partnership with I-Mab. Founded in 2003, the company is headquartered in Shanghai, China, and operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more...
執行長
Mr. Wanyong Lian
員工
108217
國家
美國
ISIN
US82937K1016

上市

0 Comments

分享你的想法

FAQ

Sinopharm Group 今天的股價是多少?
SHTDY 目前價格為 $11.01 USD,過去 24 小時上漲了 +1.72%。在圖表上更密切關注 Sinopharm Group 股價表現。
Sinopharm Group 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Sinopharm Group 的股票以代號 SHTDY 進行交易。
Sinopharm Group 的股價在上漲嗎?
SHTDY 股票較上週上漲 +2.85%,本月下跌 -2.65%,過去一年 Sinopharm Group 下跌 -8.63%。
Sinopharm Group 的市值是多少?
今天 Sinopharm Group 的市值為 34.36B
Sinopharm Group 下一次財報日期是什麼時候?
Sinopharm Group 將於 August 31, 2026 公布下一次財報。
Sinopharm Group 上一季度的財報如何?
SHTDY 上一季度的財報為每股 0.17 USD,預估為 0.16 USD,帶來 +3.51% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Sinopharm Group 去年的營收是多少?
Sinopharm Group 去年的營收為 160.38BUSD。
Sinopharm Group 去年的淨利是多少?
SHTDY 去年的淨收益為 1.93BUSD。
Sinopharm Group 會發放股息嗎?
是的,SHTDY 的股息每 年度 發放一次。每股最新股息為 0.47 USD。截至今日,股息殖利率(FWD)% 為 4.71%。
Sinopharm Group 有多少名員工?
截至 June 16, 2026,公司共有 108,217 名員工。
Sinopharm Group 位於哪個產業?
Sinopharm Group從事於Health & Wellness產業。
Sinopharm Group 何時完成拆股?
Sinopharm Group 最近沒有進行任何拆股。
Sinopharm Group 的總部在哪裡?
Sinopharm Group 的總部位於 美國 的 Shanghai。